DMAAU

Drugs Made In America Acquisition Corp Units
DMAAU

15 hedge funds and large institutions have $33.4M invested in Drugs Made In America Acquisition Corp Units in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.58M
2
+$6.14M
3
+$5.06M
4
RCM
Rivernorth Capital Management
Florida
+$4.28M
5
CCM
Context Capital Management
California
+$2.54M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Heights Capital Management
California
$6.58M
BFM
2
Boothbay Fund Management
New York
$6.14M
WCMNY
3
Westchester Capital Management (New York)
New York
$5.06M
RCM
4
Rivernorth Capital Management
Florida
$4.28M
CCM
5
Context Capital Management
California
$2.54M
SSA
6
Schonfeld Strategic Advisors
New York
$2.39M
BI
7
Bulldog Investors
New Jersey
$1.32M
WAM
8
Wolverine Asset Management
Illinois
$1.32M
Parallax Volatility Advisers
9
Parallax Volatility Advisers
California
$1.02M
Verition Fund Management
10
Verition Fund Management
Connecticut
$1.01M
M
11
Murchinson
Ontario, Canada
$915K
TCM
12
Tuttle Capital Management
Connecticut
$407K
UBS Group
13
UBS Group
Switzerland
$186K
Citadel Advisors
14
Citadel Advisors
Florida
$159K
CS
15
Clear Street
New York
$59.5K